Medical Management of Bladder Cancer

Gary R. MacVicar*, Timothy M. Kuzel

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter presents a series of case studies with questions and answers on the medical management of bladder cancer. It commences with a discourse regarding a lymph node dissection. A lymph node dissection is also undertaken in all patients, and a urinary diversion, typically an ileal conduit or orthotopic neobladder, is created. However, several reports suggest that an extended lymph node dissection improves survival relative to a limited lymph node dissection, regardless of nodal status. The chapter focuses on the outcomes in metastatic bladder cancer patients. Molecular prognostic factors are also being developed based on translational study of bladder cancer specimens and preclinical models.

Original languageEnglish (US)
Title of host publicationCancer Consult
Subtitle of host publicationExpertise for Clinical Practice
PublisherWiley Blackwell
Pages628-633
Number of pages6
ISBN (Electronic)9781118589199
ISBN (Print)9781118589212
DOIs
StatePublished - Jun 20 2014

Keywords

  • Bladder cancer
  • Lymph node dissection

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Medical Management of Bladder Cancer'. Together they form a unique fingerprint.

Cite this